Table 1.
Clinical baseline characteristics of the sample (n = 20), reported as absolute and relative frequencies.
| n | % | |
|---|---|---|
| Disease stage | ||
| 0 | 4 | 20% |
| I | 10 | 50% |
| II | 6 | 30% |
| III | – | – |
| Menopausal Status at diagnosis | ||
| Pre-menopausal | 3 | 15% |
| Post-menopausal | 17 | 85% |
| Surgery type | ||
| Mastectomy | 3 | 15% |
| Quadrantectomy | 16 | 80% |
| Lumpectomy | 1 | 5% |
| Treatment in Addition to Surgery | ||
| Radiation | 7 | 35% |
| Chemotherapy | 2 | 10% |
| Radiation + Chemotherapy | 7 | 35% |
| None | 4 | 20% |
| Current Endocrine Therapy | ||
| Tamoxifen | 5 | 25% |
| Aromatase inhibitor | 10 | 50% |
| None | 5 | 25% |